Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ayurvedic Concepts supplement claims in promo literature lead to warning letter.

This article was originally published in The Tan Sheet

Executive Summary

AYURVEDIC CONCEPTS PROMOS CONTAIN "NUMEROUS" DISEASE CLAIMS, making the company's dietary supplement products unapproved drugs, FDA determines in a June 18 warning letter to the supplement importer and distributor. The letter, which resulted from inspections of the company conducted by FDA investigators on Feb. 2 and March 9, follows an FDA "courtesy letter" sent to Houston-based Ayurvedic Concepts in early 1997 ("The Tan Sheet" March 24, 1997, p. 9). The two products cited in the "courtesy letter" -- GastriCare and Gasex - - also are listed in the recent warning letter.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel